ATE504645T1 - Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon - Google Patents

Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon

Info

Publication number
ATE504645T1
ATE504645T1 AT04776894T AT04776894T ATE504645T1 AT E504645 T1 ATE504645 T1 AT E504645T1 AT 04776894 T AT04776894 T AT 04776894T AT 04776894 T AT04776894 T AT 04776894T AT E504645 T1 ATE504645 T1 AT E504645T1
Authority
AT
Austria
Prior art keywords
fructooligosaccharide
coding
compounds
nucleic acids
fos
Prior art date
Application number
AT04776894T
Other languages
English (en)
Inventor
Rodolphe Barrangou
Todd R Klaenhammer
Eric Altermann
Original Assignee
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina State filed Critical Univ North Carolina State
Application granted granted Critical
Publication of ATE504645T1 publication Critical patent/ATE504645T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT04776894T 2003-06-23 2004-06-22 Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon ATE504645T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48076403P 2003-06-23 2003-06-23
PCT/US2004/019924 WO2005001057A2 (en) 2003-06-23 2004-06-22 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof

Publications (1)

Publication Number Publication Date
ATE504645T1 true ATE504645T1 (de) 2011-04-15

Family

ID=33551945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776894T ATE504645T1 (de) 2003-06-23 2004-06-22 Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon

Country Status (7)

Country Link
US (3) US7407787B2 (de)
EP (3) EP2322540A1 (de)
JP (2) JP4866725B2 (de)
AT (1) ATE504645T1 (de)
AU (2) AU2004252528B8 (de)
DE (1) DE602004032144D1 (de)
WO (1) WO2005001057A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2228379A1 (de) * 2003-04-25 2010-09-15 North Carolina State University Für Zelloberflächenproteinhomologe codierende Nukleinsäuresequenzen aus Lactobacillus acidophilus
WO2005001057A2 (en) 2003-06-23 2005-01-06 North Carolina State University Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
US7455992B2 (en) 2004-02-23 2008-11-25 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore
US7608700B2 (en) 2004-03-08 2009-10-27 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
US7459289B2 (en) 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
US7550576B2 (en) * 2004-08-09 2009-06-23 North Carolina State University Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
WO2006047680A2 (en) 2004-10-27 2006-05-04 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
US7495092B2 (en) * 2005-01-14 2009-02-24 North Carolina State University Compositions comprising promoter sequences and methods of use
JP5998130B2 (ja) * 2010-07-12 2016-09-28 ユニヴェルシテイト ヘントＵｎｉｖｅｒｓｉｔｅｉｔ Ｇｅｎｔ 付加価値バイオ生成物の生成のための代謝操作された生物
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP4000596A1 (de) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptid und zusammensetzungen mit tetrapeptiden
EP4000595A1 (de) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptid und zusammensetzungen mit tetrapeptiden
CN117721054B (zh) * 2023-12-12 2025-01-28 四川大学 一种提高乳酸菌在盐胁迫下生物膜产量的方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
JPS59166086A (ja) 1983-03-09 1984-09-19 Teruhiko Beppu 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
US4689406A (en) 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
US4738921A (en) 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US5028530A (en) 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
JPS63123383A (ja) 1986-11-11 1988-05-27 Mitsubishi Kasei Corp ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
JP2897959B2 (ja) 1988-05-20 1999-05-31 エフ．ホフマン―ラ ロシュ アクチェンゲゼルシャフト 固定化された配列特異的プローブ
US5412087A (en) 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
EP1382386A3 (de) 1992-02-19 2004-12-01 The Public Health Research Institute Of The City Of New York, Inc. Neue Ordnungen für Oligonukleotide und ihr Nutzen zum Sortieren, Isolieren, Sequenzierung und Manipulieren von Nukleinsäuren
US5837509A (en) * 1992-12-30 1998-11-17 Bioteknologisk Institut Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same
US5532142A (en) 1993-02-12 1996-07-02 Board Of Regents, The University Of Texas System Method of isolation and purification of fusion polypeptides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5861242A (en) 1993-06-25 1999-01-19 Affymetrix, Inc. Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same
JP3954092B2 (ja) 1993-06-25 2007-08-08 アフィメトリックス インコーポレイテッド 核酸配列のハイブリダイゼーションと配列決定
US6309823B1 (en) 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5716837A (en) * 1995-02-10 1998-02-10 Monsanto Company Expression of sucrose phosphorylase in plants
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
WO2000078922A2 (en) 1999-06-21 2000-12-28 North Carolina State University Acid-inducible promoters for gene expression
WO2000078784A1 (en) * 1999-06-23 2000-12-28 Smithkline Beecham Corporation treP
WO2001007463A1 (en) * 1999-07-22 2001-02-01 Smithkline Beecham Corporation Trer
US6544772B1 (en) * 2000-08-08 2003-04-08 Genesis Research & Development Corp. Ltd Polynucleotides, materials incorporating them, and methods for using them
US7125698B2 (en) 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
US7026463B2 (en) * 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
US6476209B1 (en) * 2000-11-28 2002-11-05 Genesis Research & Development Corporation Ltd. Polynucleotides, materials incorporating them, and methods for using them
US6635460B1 (en) * 2000-05-25 2003-10-21 Nederlandse Organisatie Voor Toegepast - Natuurwetenschappelijk Onderzoek Tno Fructosyltransferases
AU2001284558B2 (en) * 2000-08-08 2007-01-04 Genesis Research And Development Corporation Limited Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
IL156490A0 (en) * 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
EP1227152A1 (de) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bakterienstamm und Genom des Bifidobacteriums
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
DK1497422T3 (da) 2002-04-09 2008-12-15 Nestle Sa LA1 - genormet af en Lactobacillus-stamme
EP1394176A1 (de) 2002-08-27 2004-03-03 Nestec S.A. Neue Mucin bindende Polypeptide abstammend von Lactobacillus johnsonii
EP1590443A4 (de) 2003-01-29 2009-01-07 Osel Inc Oberflächenexpression biologisch aktiver proteine in bakterien
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
EP2228379A1 (de) 2003-04-25 2010-09-15 North Carolina State University Für Zelloberflächenproteinhomologe codierende Nukleinsäuresequenzen aus Lactobacillus acidophilus
WO2005001057A2 (en) 2003-06-23 2005-01-06 North Carolina State University Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
US7459289B2 (en) * 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
US7608700B2 (en) * 2004-03-08 2009-10-27 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor

Also Published As

Publication number Publication date
EP1651750B1 (de) 2011-04-06
DE602004032144D1 (de) 2011-05-19
WO2005001057A3 (en) 2006-09-21
US20110008292A1 (en) 2011-01-13
US20050123941A1 (en) 2005-06-09
WO2005001057A2 (en) 2005-01-06
US7824894B2 (en) 2010-11-02
AU2004252528A1 (en) 2005-01-06
JP4866725B2 (ja) 2012-02-01
AU2004252528B8 (en) 2010-08-05
AU2010214772A1 (en) 2010-09-23
JP2012050448A (ja) 2012-03-15
EP2322540A1 (de) 2011-05-18
EP1651750A4 (de) 2007-03-14
US7407787B2 (en) 2008-08-05
JP2007527702A (ja) 2007-10-04
EP2319863A1 (de) 2011-05-11
US20090005311A1 (en) 2009-01-01
EP1651750A2 (de) 2006-05-03
AU2004252528B2 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
WO2005086794A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
EP2392581A3 (de) Nukleinsäurensequenzen, die für Proteine an der Zelloberfläche von Lactobacillus acidophilus kodieren und deren Verwendung
DE602004032144D1 (de) Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
DK1534830T3 (da) In vito-peptid-ekspressionsbibliotek
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
WO2002070652A3 (en) Novel molecules of the card-related protein family and uses thereof
WO2005084411A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2006047680A3 (en) Lactobacillus acidophilus nucleic acids and uses thereof
WO2005081959A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefor
WO2001061005A3 (en) Molecules of the pyrin domain protein family and uses thereof
WO2002103015A3 (en) Abca10 transporter
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
WO2002068591A3 (en) G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof
WO2003029434A3 (en) Novel molecules of the hkid-1-related protein family and uses thereof
WO2001077151A3 (en) Fdrg proteins and nucleic acid molecules and uses therefor
WO2001059065A3 (en) Novel molecules of the card-related protein family and uses thereof
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use
WO2002070691A3 (en) Abcg4 transporter and uses thereof
WO2001083523A3 (en) Stmst protein and nucleic acid molecules and uses therefor
WO2003089588A3 (en) Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
AU2002234132A1 (en) 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
WO2002018439A3 (en) 52991, a human transporter protein and uses therefor
WO2001066765A3 (en) 26583, a serine/threonine phosphatase and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties